Tirzepatide
Product Overview
Tirzepatide is a dual agonist peptide that targets both the GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic polypeptide) receptors. This dual-pathway activity has made it a widely studied compound in metabolic research, particularly for its role in glucose regulation, insulin response, and energy balance.
By engaging two complementary incretin pathways, Tirzepatide allows researchers to investigate how hormonal signaling influences nutrient utilization, metabolic efficiency, and systemic energy regulation. It is often used as a foundational compound in incretin-based research models and serves as a valuable comparison point for more complex multi-pathway peptides.
Tirzepatide is commonly incorporated into research protocols focused on metabolic signaling, glycemic control mechanisms, and the interaction between insulin response and energy regulation pathways.
Mechanism of Action
Tirzepatide exerts its effects through dual receptor activation:
GLP-1 receptor activationAssociated with appetite signaling, gastric regulation, and glucose metabolism
GIP receptor activationPlays a role in insulin secretion, nutrient partitioning, and metabolic signaling
The combined activation of these incretin pathways provides a more integrated model for studying metabolic regulation compared to single-pathway compounds.
Key Research Applications
Incretin pathway signaling studies
Glucose regulation and insulin response modeling
Metabolic efficiency and nutrient partitioning
Appetite and satiety pathway research
Comparative studies with multi-pathway agonists
Product Specifications
Quantity: 20mg
Form: Lyophilized powder
Purity: ≥98% (HPLC tested)
Appearance: White to off-white powder
Storage:
Long-term: -20°C
Short-term (reconstituted): 2–8°C
Reconstitution Guidance (General Laboratory Use)
Tirzepatide is supplied in lyophilized form and must be reconstituted prior to use in a controlled laboratory setting.
Use sterile bacteriostatic water for reconstitution
Introduce solution slowly along the vial wall
Gently swirl—do not shake
Concentration and handling protocols should be determined based on specific research objectives.
Quality Assurance
Third-party tested for purity and identity
Batch-specific Certificate of Analysis (COA) available
Manufactured in controlled laboratory environments
What’s Included
1 × 20mg Tirzepatide lyophilized vial
COA access for batch verification
Research Use Notice
For research use only. Not intended for human consumption.
